Phase I/IIa Study for AZD5335 as monotherapy and in combination with anti-cancer agents in participants with Solid Tumors

Trial Identifier: D8990C00001
Sponsor: AstraZeneca
Start Date: May 2023
Primary Completion Date: October 2027
Study Completion Date: October 2027
Condition: Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA Duarte, CA, US, 91010
US, CA La Jolla, CA, US, 92093
US, KY Louisville, KY, US, 40202
US, MA Boston, MA, US, 02114
US, OH Columbus, OH, US, 43201
US, OR Portland, OR, US, 97239
US, TX Houston, TX, US, 77030